Diametric Capital, LP Landec Corp \Ca\ Transaction History
Diametric Capital, LP
- $157 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding LNDC
# of Institutions
77Shares Held
20.2MCall Options Held
114KPut Options Held
82.1K-
Wynnefield Capital Inc New York, NY4.92MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA2.95MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT2.14MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
-
325 Capital LLC New York, NY1.34MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...